Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS)-is it one disease or an overlap of two disorders?

Digestive Diseases and Sciences

Volumn 54, Issue 9, 2009, Pages 1829-1834

  Gasiorowska, Anita ^a   Poh, Choo Hean ^a   Fass, Ronnie ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Gastroesophageal reflux disease (GERD); Irritable bowel syndrome (IBS); Pathophysiologic mechanism; Symptom assessment; Visceral hyperalgesia

Indexed keywords

PROTON PUMP INHIBITOR;

CLINICAL FEATURE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; HUMAN; IRRITABLE COLON; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW;

GASTROESOPHAGEAL REFLUX; HUMANS; IRRITABLE BOWEL SYNDROME; PREVALENCE;

EID: 68249135715     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0594-2     Document Type: Review

References (41)

1. YA Saito P Schoenfeld GR Locke 3rd 2002 The epidemiology of irritable bowel syndrome in North America: a systematic review Am J Gastroenterol 97 1910 1915 (Pubitemid 34906835)
2. NJ Talley P Boyce M Jones 1998 Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population Gut 42 690 695
3. R Spiller Q Aziz F Creed A Emmanuel L Houghton P Hungin R Jones D Kumar G Rubin N Trudgill P Whorwell 2007 Clinical services committee of the British society of gastroenterology: guidelines on the irritable bowel syndrome: mechanisms and practical management Gut 56 1770 1798 10.1136/gut.2007.119446 (Pubitemid 350206308)
4. CM Mitchell DA Drossman 1987 Survey of the AGA membership relating to patients with functional gastrointestinal disorders Gastroenterology 92 1282 1284
5. M Fullard JY Kang P Neild A Poullis JD Maxwell 2006 Systematic review: does gastro-oesophageal reflux disease progress? Aliment Pharmacol Ther 24 33 45 10.1111/j.1365-2036.2006.02963.x (Pubitemid 43894003)
6. TK Cheung KF Lam WH Hu CL Lam WM Wong WM Hui KC Lai SK Lam BC Wong 2007 Positive association between gastro-oesophageal reflux disease and irritable bowel syndrome in a Chinese population Aliment Pharmacol Ther 25 1099 1104
7. Hu WH, Wong WM, Lam CL, et al. Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population-based study. Aliment Pharmacol Ther. 2002;16:2081-2088. doi: 10.1046/j.1365-2036.2002.01377.x. (Pubitemid 36009172)
8. NJ Talley EH Dennis V Schettler-Duncan BE Lacy KW Olden MD Crowell 2003 Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea Am J Gastroenterol 98 2454 2459 10.1111/j.1572-0241.2003.07699.x (Pubitemid 37448756)
9. B Zimmerman T Hershcovici 2008 Bowel symptoms in nonerosive gastroesophageal reflux disease: nature, prevalence, and relation to acid reflux J Clin Gastroenterol 42 261 265
10. L Agreus K Svardsudd NJ Talley MP Jones G Tibblin 2001 Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study Am J Gastroenterol 96 2905 2914
11. GR Locke 3rd AR Zinsmeister SL Fett LJ Melton 3rd NJ Talley 2005 Overlap of gastrointestinal symptom complexes in a US community Neurogastroenterol Motil 17 29 34 10.1111/j.1365-2982.2004.00581.x (Pubitemid 40204009)
12. M Pimentel F Rossi EJ Chow J Ofman H Fullerton P Hassard HC Lin 2002 Increased prevalence of irritable bowel syndrome in patients with gastroesophageal reflux J Clin Gastroenterol 34 221 224 10.1097/00004836- 200203000-00004 (Pubitemid 34177372)
13. WM Wong R Fass 2004 Extraesophageal and atypical manifestations of GERD J Gastroenterol Hepatol 19 S33 S43 10.1111/j.1440-1746.2004.03589.x (Pubitemid 39237421)
14. AP Hungin L Chang GR Locke EH Dennis V Barghout 2005 Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact Aliment Pharmacol Ther 21 1365 1375 10.1111/j.1365-2036.2005.02463.x (Pubitemid 40813683)
15. J Zimmerman 2003 Extraintestinal symptoms in irritable bowel syndrome and inflammatory bowel diseases: nature, severity, and relationship to gastrointestinal symptoms Dig Dis Sci 48 743 749 10.1023/A:1022840910283 (Pubitemid 36390678)
16. TM Kennedy RH Jones AP Hungin H O'Flanagan P Kelly 1998 Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population Gut 43 770 774
17. DR De Vries MA Van Herwaarden A Baron AJ Smout M Samsom 2007 Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease Scand J Gastroenterol 42 951 956 10.1080/00365520701204204 (Pubitemid 47037124)
18. J Zimmerman 2004 Irritable bowel, smoking and oesophageal acid exposure: an insight into the nature of symptoms of gastro-oesophageal reflux Aliment Pharmacol Ther 20 1297 1303 10.1111/j.1365-2036.2004.02216.x (Pubitemid 40040076)
19. R Fass V Stanghellini H Monnikes 2006 Baseline analysis of symptom spectrum in GERD clinical trial patients: result from ReQuest database Gastroenterology 130 A629
20. F Guillemot P Ducrotte L Bueno 2005 Prevalence of functional gastrointestinal disorders in a population of subjects consulting for gastroesophageal reflux disease in general practice Gastroenterol Clin Biol 29 243 246 10.1016/S0399-8320(05)80756-0
21. I Nastaskin E Mehdikhani J Conklin S Park M Pimentel 2006 Studying the overlap between IBS and GERD: a systematic review of the literature Dig Dis Sci 51 2113 2120 10.1007/s10620-006-9306-y
22. HL Smart DA Nicholson M Atkinson 1986 Gastro-oesophageal reflux in the irritable bowel syndrome Gut 27 1127 1131 10.1136/gut.27.10.1127
23. PJ Whorwell M [tmp] McCallum FH Creed CT Roberts 1986 Non-colonic features of irritable bowel syndrome Gut 27 37 40 10.1136/gut.27.1.37
24. NJ Talley 2006 A unifying hypothesis for the functional gastrointestinal disorders: really multiple diseases or one irritable gut? Rev Gastroenterol Disord 6 72 78
25. NJ Talley 2006 Overlapping abdominal symptoms: why do GERD and IBS often coexist? Drugs Today (Barc) 42 3 8 10.1358/dot.2006.42.1.893611 (Pubitemid 46422078)
26. A Lembo M Zaman M Jones NJ Talley 2007 Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study Aliment Pharmacol Ther 25 1343 1350
27. R Dickman H Feroze R Fass 2006 Gastroesophageal reflux disease and irritable bowel syndrome: a common overlap syndrome Curr Gastroenterol Rep 8 261 265 10.1007/s11894-006-0045-1
28. R Jones S Lydeard 1992 Irritable bowel syndrome in the general population BMJ 304 87 90
29. M Costantini GC Sturniolo G Zaninotto R D'Incà R Polo R Naccarato E Ancona 1993 Altered esophageal pain threshold in irritable bowel syndrome Dig Dis Sci 38 206 212 10.1007/BF01307536 (Pubitemid 23054352)
30. JH Rubenstein B Nojkov S Korsnes SA Adlis MJ Shaw B Weinman J Inadomi R Saad WD Chey 2007 Oesophageal hypersensitivity is associated with features of psychiatric disorders and the irritable bowel syndrome Aliment Pharmacol Ther 26 443 453
31. KC Trimble R Farouk A Pryde S Douglas RC Heading 1995 Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity Dig Dis Sci 40 1607 1613 10.1007/BF02212678
32. R Fass 2008 Persistent heartburn in a patient on proton-pump inhibitor Clin Gastroenterol Hepatol 6 393 400 10.1016/j.cgh.2008.02.016
33. R Fass 2007 Proton-pump inhibitor therapy in patients with gastro-oesophageal reflux disease: putative mechanisms of failure Drugs 67 1521 1530 10.2165/00003495-200767110-00001 (Pubitemid 47267295)
34. HK Jung S Halder M [tmp] McNally GR Locke III CD Schleck AR Zinsmeister NJ Talley 2007 Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population Aliment Pharmacol Ther 26 453 461
35. B Nojkov JH Rubenstein SA Adlis MJ Shaw R Saad J Rai B Weinman WD Chey 2008 The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease Aliment Pharmacol Ther 27 473 482
36. Y Raftopoulos P Papasavas R Landreneau F Hayetian T Santucci D Gagné P Caushaj R Keenan 2004 Clinical outcome of laparoscopic antireflux surgery for patients with irritable bowel syndrome Surg Endosc 18 655 659 10.1007/s00464-003-8162-5 (Pubitemid 38569117)
37. J Kountouras D Chatzopoulos C Zavos P Boura J Venizelos A Kalis 2002 Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome Hepatogastroenterology 49 193 197
38. V Stanghellini D Armstrong H Mönnikes P Berghöfer G Gatz KD Bardhan 2007 Determination of ReQuest-based symptom thresholds to define symptom relief in GERD clinical studies Digestion 75 55 61 10.1159/000101083
39. D Glatzel M Abdel-Quader G Gatz B Pfaffenberger 2007 Pantoprazole 40 mg is as effective as esomeprazole 40 mg to relieve symptoms of gastroesophageal reflux disease after 4 weeks of treatment and superior regarding the prevention of symptomatic relapse Digestion 75 69 78 10.1159/000101085
40. H Monnikes B Pfaffenberger G Gatz J Hein KD Bardhan 2007 Novel measurement of rapid treatment success with ReQuest: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole Digestion 75 62 68
41. V Stanghellini 2005 ReQuest: new dimensions in the assessment and management of GERD Drugs Today (Barc) 41 7 11